|
|
Volumn 30, Issue 3, 2001, Pages 588-589
|
|
Commentary: Developing preventive strategies in Europe
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
VIRUS ANTIBODY;
COST BENEFIT ANALYSIS;
DEVELOPING COUNTRY;
EUROPE;
GENITAL HERPES;
HERPES SIMPLEX VIRUS 1;
HERPES SIMPLEX VIRUS 2;
HUMAN;
NETHERLANDS;
NOTE;
OUTPATIENT DEPARTMENT;
PREVENTIVE MEDICINE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
SCREENING;
SEROPREVALENCE;
SEXUAL TRANSMISSION;
SEXUALLY TRANSMITTED DISEASE;
UNIVERSITY HOSPITAL;
|
|
EID: 0034960335
PISSN: 03005771
EISSN: None
Source Type: Journal
DOI: 10.1093/ije/30.3.588 Document Type: Note |
|
Times cited : (5)
|
|
References (6)
|
